Nothing Special   »   [go: up one dir, main page]

UA113179C2 - Антипаразитарна композиція, яка містить макроциклічний лактон і левамізол, і спосіб лікування паразитарної інфестації - Google Patents

Антипаразитарна композиція, яка містить макроциклічний лактон і левамізол, і спосіб лікування паразитарної інфестації

Info

Publication number
UA113179C2
UA113179C2 UAA201400624A UAA201400624A UA113179C2 UA 113179 C2 UA113179 C2 UA 113179C2 UA A201400624 A UAA201400624 A UA A201400624A UA A201400624 A UAA201400624 A UA A201400624A UA 113179 C2 UA113179 C2 UA 113179C2
Authority
UA
Ukraine
Prior art keywords
composition containing
parasitary
lacton
levamisol
infestation
Prior art date
Application number
UAA201400624A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UA113179C2 publication Critical patent/UA113179C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Винахід належить до ветеринарної антипаразитарної розчиненої композиції, яка містить макроциклічний лактон або фармацевтично еквівалентну його сіль і левамізол, або фармацевтично еквівалентну його сіль, яка характеризується тим, що рН композиції знаходиться в межах від 2,0 до 5,0 і в якій композиція містить принаймні одну поверхнево-активну речовину і принаймні один антиоксидант.
UAA201400624A 2011-06-23 2012-06-22 Антипаразитарна композиція, яка містить макроциклічний лактон і левамізол, і спосіб лікування паразитарної інфестації UA113179C2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ59371311 2011-06-23
PCT/NZ2012/000104 WO2012177151A1 (en) 2011-06-23 2012-06-22 Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation

Publications (1)

Publication Number Publication Date
UA113179C2 true UA113179C2 (xx) 2016-12-26

Family

ID=47422791

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201400624A UA113179C2 (xx) 2011-06-23 2012-06-22 Антипаразитарна композиція, яка містить макроциклічний лактон і левамізол, і спосіб лікування паразитарної інфестації

Country Status (19)

Country Link
US (1) US9198430B2 (uk)
EP (1) EP2723335A4 (uk)
JP (1) JP6120834B2 (uk)
KR (1) KR20140047617A (uk)
CN (1) CN103717218B (uk)
AU (1) AU2012273538B2 (uk)
BR (1) BR112013032567B1 (uk)
CA (1) CA2839491A1 (uk)
CL (1) CL2013003501A1 (uk)
CO (1) CO6842017A2 (uk)
CR (1) CR20130642A (uk)
DO (1) DOP2013000289A (uk)
IL (1) IL230074A (uk)
MX (1) MX355769B (uk)
NI (1) NI201300139A (uk)
PE (1) PE20141179A1 (uk)
RU (1) RU2591082C2 (uk)
UA (1) UA113179C2 (uk)
WO (1) WO2012177151A1 (uk)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104470517B (zh) * 2012-07-17 2018-12-18 拜耳新西兰有限公司 注射用抗生素制剂及其使用方法
JP6499970B2 (ja) * 2013-10-30 2019-04-10 大蔵製薬株式会社 服用し易いゼリー状医薬組成物
CA3095352A1 (en) * 2017-11-23 2019-05-31 Ceva Sante Animale Composition for treating parasites infestations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
EP1182931B1 (en) * 1999-06-04 2005-12-28 Nufarm Limited Stable biocidal compositions
NZ508969A (en) 1999-06-04 2002-12-20 Nufarm Ltd Pesticidal emulsion containing levamisole in the aqueous phase and a macrocyclic lactone anthelmintic in the organic phase
CN1375293A (zh) 2001-03-16 2002-10-23 王玉万 含碘醚柳胺的复方注射用驱虫药
NZ520295A (en) * 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
AU2003900505A0 (en) 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition
US7645459B2 (en) * 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
BRPI0506279B1 (pt) 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda Composição sinergística de antihelmínticos e endectocidas
NZ552040A (en) 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
NZ552293A (en) 2006-12-21 2009-03-31 Bomac Research Ltd Tablet formulation comprising a macrocyclic lactone and a levamisole compound having anthelmintic activity
AU2009283313C1 (en) 2008-08-18 2014-07-31 Intervet Ineternational B.V. Anthelmintic compositions
AU2010201490C1 (en) * 2009-04-15 2014-07-24 Zoetis Services Llc Anthelmintic formulation
NZ570591A (en) * 2009-08-18 2012-01-12 Intervet Int Bv Anthelmintic compositions
NZ603699A (en) * 2010-05-12 2013-08-30 Merial Ltd Injectable parasiticidal formulations of levamisole and macrocyclic lactones

Also Published As

Publication number Publication date
KR20140047617A (ko) 2014-04-22
RU2014101995A (ru) 2015-07-27
EP2723335A1 (en) 2014-04-30
CO6842017A2 (es) 2014-01-20
IL230074A (en) 2016-10-31
CN103717218B (zh) 2017-09-12
NI201300139A (es) 2014-02-26
RU2591082C2 (ru) 2016-07-10
PE20141179A1 (es) 2014-10-11
WO2012177151A1 (en) 2012-12-27
BR112013032567A2 (pt) 2017-01-24
CA2839491A1 (en) 2012-12-27
JP6120834B2 (ja) 2017-04-26
DOP2013000289A (es) 2014-03-16
EP2723335A4 (en) 2015-01-07
CL2013003501A1 (es) 2014-06-27
AU2012273538A1 (en) 2013-05-02
CR20130642A (es) 2014-02-19
US20140221299A1 (en) 2014-08-07
MX2013014460A (es) 2014-04-14
CN103717218A (zh) 2014-04-09
BR112013032567B1 (pt) 2020-04-28
JP2014517066A (ja) 2014-07-17
US9198430B2 (en) 2015-12-01
MX355769B (es) 2018-04-30
AU2012273538B2 (en) 2015-11-19

Similar Documents

Publication Publication Date Title
MX2018015892A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
EA201891674A1 (ru) Ингибиторы лизилоксидаз, представляющие собой индольные и азаиндольные производные галогеналлиламина, и их применения
CN106536480A8 (zh) 吡咯烷‑2,5‑二酮衍生物、药物组合物及用作ido1抑制剂的方法
BR112018003026A2 (pt) composições compreendendo um inibidor de pi3k e um inibidor de hdac
PL420160A1 (pl) Weterynaryjne doustne kompozycje przeciwpasożytnicze obejmujące działające systemowo substancje czynne, sposoby i zastosowania je obejmujące
EA201490817A1 (ru) Композиции этанерцепта, стабилизированные ионами металлов
BR112014017749A8 (pt) Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo
EA201200323A1 (ru) Соединения и композиции, как ингибиторы протеинкиназы
EA201391536A1 (ru) Противомикробные соединения и способы их получения и применения
EA201170772A1 (ru) Органические соединения
EA202092620A1 (ru) Соли и твердые формы монобактамного антибиотика
MA43918A (fr) Composition pharmaceutique pour la prã‰vention et/ou le traitement de la dermatite atopique contenant comme principe actif un antagoniste de l'il-31
EA201600124A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
FR3005420B1 (fr) Procede de stabilisation de suspensions d'erythrocytes encapsulant un principe actif, suspensions obtenues.
EA201690783A1 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
EA201690227A1 (ru) Азаиндольные соединения, их получение и способы их применения
EA201791845A1 (ru) Твердые формы менахинолов
EA201591717A1 (ru) Твердые формы гидрохлорида вемурафениба
EA201790699A1 (ru) Стабилизированные производные адреномедуллина и их применение
UA113179C2 (xx) Антипаразитарна композиція, яка містить макроциклічний лактон і левамізол, і спосіб лікування паразитарної інфестації
MX2018016339A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
EA201890419A1 (ru) ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ
CR20150508A (es) Formulaciones veterinarias estables de combinación de lactonas macrocíclicas e imidazotiazoles
EA202090750A1 (ru) Производные глюконовой кислоты для применения в лечении и/или предупреждении инфекций, вызываемых микроорганизмами
EA201270547A1 (ru) Фармацевтическая композиция